Explainer
Evidence-led entry points for non-clinicians. What is a GLP-1 receptor agonist, what does ATC A10BX mean, why are some peptides legal in Russia but not the EU.
Radiolabeling peptides in fewer steps
A 2026 study reports a hydroformylation method that installs carbon-14 or tritium labels on peptides, including semaglutide analogs.
Stopping semaglutide before abdominoplasty
A retrospective study of 80 patients finds that stopping semaglutide four weeks before abdominoplasty normalised complication rates.
Tb4 with ciprofloxacin restores eye nerves
A 2026 mouse study finds topical thymosin beta-4 with ciprofloxacin restores nerve density and vision after bacterial keratitis.
Peptide Stacks With Tirzepatide
No clinical trial has studied BPC-157, TB-500, or CJC-1295 in combination with tirzepatide. Here is what the evidence shows.
Wegovy weight loss pill gets UK approval
The MHRA approved oral Wegovy (semaglutide 25 mg tablets) for weight management in adults on 11 June 2026, making it the first oral GLP-1 for obesity in the UK.
Optic neuropathy after semaglutide ramp-up
A 2026 case report describes atypical optic nerve damage behind the eye in a man on semaglutide 1 mg weekly, broadening the known spectrum of eye-related risks.
Biopsy-free MASH trials need longer runs
Ajmera and Loomba argue that NIT-based MASH trials must extend beyond 52 weeks and use composite non-invasive endpoints to capture fibrosis change.
CJC-1295/Ipamorelin 10 mg Blend Dosing
How to calculate the dose from a CJC-1295/ipamorelin 10 mg blend vial. Step-by-step reconstitution math and what the research actually supports.
CJC-1295 and Ipamorelin Hives Explained
Hives at old CJC-1295 and ipamorelin injection sites are usually mast-cell driven, not a true allergy. Here is what the literature says.
Dulaglutide in 2026: still relevant?
A narrative review argues dulaglutide still earns its place in cardiometabolic care despite tirzepatide and semaglutide gaining ground.
Dupuytren's contracture and peptides
Dupuytren's contracture surfaces in peptide forums alongside GLP-1 drugs. The biological overlap with fibrotic pathways is real. The direct evidence is not.
GLP-1 add-on doubled time in range: Ramadan
A 2026 CGM study found that adding semaglutide or tirzepatide to insulin doubled time in range during Ramadan fasting without raising hypoglycaemia risk.